Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors
Two early-phase clinical trials presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by researchers from The University of Texas MD Anderson Cancer Center demonstrate promising responses and safety ...
Jun 3, 2024
0
0
